UTI Asset Management Company Limited (UTIAMC) is one of India’s oldest and most trusted asset management companies, managing over ₹2.5 lakh crore in assets under management (AUM) as of FY26. As the manager of UTI Mutual Fund—the first mutual fund in India—UTIAMC benefits from strong brand recognition, a diversified product portfolio, and rising retail participation in mutual funds. With consistent profitability, zero promoter holding, and a high dividend yield, it appeals to income-focused investors. This article provides a fact-based analysis of its financials and estimates a realistic share price target for 2026 through 2030.
Ownership: No promoters; owned by public and institutional shareholders
Listed On: BSE (543217) and NSE (UTIAMC)
UTI AMC: Key Financial Snapshot
Metric
Value
Market Capitalization
₹13,642.95 Cr
Current Share Price
₹1,061 (approx.)
P/E (TTM)
21.65
P/B (TTM)
3.71
Book Value (TTM)
₹285.76
EPS (TTM)
₹49.02
ROE
17.81%
ROCE
23.71%
Dividend Yield
4.52%
Sales Growth (YoY)
8.37%
Profit Growth (YoY)
8.83%
Operating Revenue
₹1,449.21 Cr
Net Profit
₹653.52 Cr
Advances
₹7.40 Cr
Face Value
₹10
No. of Shares
12.85 Cr
Shareholding Pattern
Category
Holding (%)
Domestic Institutions (DII)
60.00%
Public (Retail)
32.73%
Foreign Institutions (FII)
7.27%
Promoters
0%
Others
0%
The company has no promoters, with DIIs (including banks and insurance firms) holding a majority stake—reflecting strong institutional confidence.
UTI AMC Share Price Target Forecast (2026–2030)
Based on earnings stability, dividend consistency, mutual fund industry tailwinds, and historical valuation, we estimate the following realistic price ranges:
Year
Target Price Range (₹)
2026
₹1,100 – ₹1,250
2027
₹1,150 – ₹1,350
2028
₹1,200 – ₹1,450
2029
₹1,250 – ₹1,550
2030
₹1,300 – ₹1,650
Year-wise Breakdown
UTI AMC Share Price Target 2026
Year
Share Price Target 1
Share Price Target 2
2026
₹1,100
₹1,250
Strong ROCE (23.7%) and ROE (17.8%) support a premium valuation.
At a P/E of 21.6x, the stock is fairly valued for a stable AMC.
High dividend yield (4.52%) offers downside protection.
UTI AMC Share Price Target 2027
Year
Share Price Target 1
Share Price Target 2
2027
₹1,150
₹1,350
Rising SIP inflows and mutual fund penetration in Tier II/III cities boost AUM.
Low operating leverage ensures margin resilience during market volatility.
Institutional ownership (60% DII) provides liquidity and stability.
UTI AMC Share Price Target 2028
Year
Share Price Target 1
Share Price Target 2
2028
₹1,200
₹1,450
Expansion in passive funds (ETFs, index funds) may drive low-cost AUM growth.
Recurring management fee income offers earnings visibility.
Potential inclusion in more indices could attract passive flows.
UTI AMC Share Price Target 2029
Year
Share Price Target 1
Share Price Target 2
2029
₹1,250
₹1,550
By 2029, India’s mutual fund AUM could cross ₹50 lakh crore, benefiting incumbents.
UTI’s legacy brand continues to attract conservative investors.
However, intense competition from private AMCs caps aggressive upside.
UTI AMC Share Price Target 2030
Year
Share Price Target 1
Share Price Target 2
2030
₹1,300
₹1,650
As a pure-play AMC with no promoter risk, UTIAMC is a safe compounder.
Realistic 2030 target assumes EPS of ₹65–70 and P/E of 20–23x.
Long-term growth tied to India’s financial savings rate, not explosive expansion.
Strengths vs Risks
✅ Strengths
Zero promoter holding eliminates governance concerns
High dividend yield (4.52%) with consistent payout (~95% of profits)
Strong ROCE (23.7%) and capital-light model
Beneficiary of India’s mutual fund adoption and SIP culture
⚠️ Risks
No control over market-linked AUM—revenue dips during equity corrections
Intense competition from HDFC, ICICI, SBI, and Nippon AMCs
Limited growth levers—business is mature and fee-sensitive
No promoter skin-in-the-game may reduce strategic urgency
Investment Suitability
Factor
Assessment
Risk Profile
Low to Moderate
Time Horizon
Long-term (5+ years)
Volatility
Low (defensive financial stock)
Dividend/Income
Yes (4.52% yield + stable)
Ideal Investor
Income-seeking, conservative, believes in India’s mutual fund story
FAQs
A realistic range is ₹1,100 to ₹1,250, based on current earnings and dividend yield.
We estimate ₹1,300 to ₹1,650 by 2030, assuming steady AUM growth and stable margins.
Reliable forecasts beyond 2030 are not possible. Such long-term projections are highly speculative and not supported by verifiable data.
There are no promoters. The company is owned by DIIs (60%), public (32.73%), and FIIs (7.27%).
Yes – it has one of the highest dividend yields (4.52%) among listed AMCs, with a near-100% payout ratio.
The stock may correct due to broader market volatility, decline in equity AUM, or profit-taking after strong rallies.
It is suitable for conservative, income-focused investors seeking exposure to India’s mutual fund growth with low risk. Not ideal for high-growth seekers.
Final Verdict
UTI AMC is a high-quality, capital-efficient business with strong cash flows and generous dividends. While it lacks explosive growth potential, its defensive characteristics, institutional backing, and role in India’s financialization make it a reliable long-term holding. Our 2026–2030 price targets (₹1,100–₹1,650) reflect steady, dividend-supported appreciation—not speculative upside. Investors should view it as a core income-generating asset in a diversified portfolio.
📌 Disclaimer: These targets are for educational purposes only and are not investment advice. Always consult a SEBI-registered advisor before investing.
Hi, I’m Raj Mittal, a stock market content writer focused on company analysis, share price trends, and fundamental research. I create simple, research-based insights to help investors make smarter market decisions.
